Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Stephens

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
BJU International|January 20, 2026
Area deprivation and cancer-specific mortality in non-muscle-invasive bladder cancer: a statewide analysisCarlo Silvani, Alfonso Santangelo, Jack Considine, et al.
The Prostate|August 11, 2025
Mortality and Additional Treatment Rates in Pathologically High-Risk Prostate Cancer With Prostate-Specific Antigen Persistence at Robot-Assisted Radical Prostatectomy: Long-Term Report From Single Tertiary Referral CenterAlessandro Bertini, Alex Stephens, Alessio Finocchiaro, et al.
BJU International|July 30, 2025
Socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivation Index on PSA screening frequencyAlessandro Bertini, Giuseppe Ottone Cirulli, Alex Stephens, et al.
Clinical Genitourinary Cancer|June 13, 2025
The Role of Cytoreductive Nephrectomy in Contemporary Metastatic Renal Cell Carcinoma: An Other-Cause Mortality Match Population-Based StudyMarco Finati, Giuseppe Ottone Cirulli, Giuseppe Chiarelli, et al.
The Prostate|March 11, 2025
Socioeconomic Disparities in Prostate Cancer Treatment: The Impact of Area Deprivation Index on Initial Treatment Type for Localized PCa in a North-American CohortSilvia Viganò, Marco Finati, Alex Stephens, et al.
Urologic Oncology|March 24, 2024
Testing the external validity of the POUT III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohortNicholas James Corsi, Alex Stephens, Marco Finati, et al.
World Journal of Urology|September 29, 2025
Association of area of deprivation index with magnetic resonance imaging (MRI) utilization for prostate cancer detection: results from a contemporary North American populationAlessandro Bertini, Alex Stephens, Alessio Finocchiaro, et al.
JNCI Cancer Spectrum|November 22, 2024
Association of race and area of deprivation index with prostate cancer incidence and lethality: results from a contemporary North American cohortMarco Finati, Alex Stephens, Giuseppe Ottone Cirulli, et al.
European Urology Oncology|July 11, 2024
The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American CohortMarco Finati, Matthew Davis, Alex Stephens, et al.
Urologic Oncology|September 6, 2024
Radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer: Analysis of an other-cause mortality matched cohortMarco Finati, Alex Stephens, Giuseppe Chiarelli, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
BJU International|January 20, 2026
Area deprivation and cancer-specific mortality in non-muscle-invasive bladder cancer: a statewide analysisCarlo Silvani, Alfonso Santangelo, Jack Considine, et al.
The Prostate|August 11, 2025
Mortality and Additional Treatment Rates in Pathologically High-Risk Prostate Cancer With Prostate-Specific Antigen Persistence at Robot-Assisted Radical Prostatectomy: Long-Term Report From Single Tertiary Referral CenterAlessandro Bertini, Alex Stephens, Alessio Finocchiaro, et al.
BJU International|July 30, 2025
Socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivation Index on PSA screening frequencyAlessandro Bertini, Giuseppe Ottone Cirulli, Alex Stephens, et al.
Clinical Genitourinary Cancer|June 13, 2025
The Role of Cytoreductive Nephrectomy in Contemporary Metastatic Renal Cell Carcinoma: An Other-Cause Mortality Match Population-Based StudyMarco Finati, Giuseppe Ottone Cirulli, Giuseppe Chiarelli, et al.
The Prostate|March 11, 2025
Socioeconomic Disparities in Prostate Cancer Treatment: The Impact of Area Deprivation Index on Initial Treatment Type for Localized PCa in a North-American CohortSilvia Viganò, Marco Finati, Alex Stephens, et al.
Urologic Oncology|March 24, 2024
Testing the external validity of the POUT III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohortNicholas James Corsi, Alex Stephens, Marco Finati, et al.
World Journal of Urology|September 29, 2025
Association of area of deprivation index with magnetic resonance imaging (MRI) utilization for prostate cancer detection: results from a contemporary North American populationAlessandro Bertini, Alex Stephens, Alessio Finocchiaro, et al.
JNCI Cancer Spectrum|November 22, 2024
Association of race and area of deprivation index with prostate cancer incidence and lethality: results from a contemporary North American cohortMarco Finati, Alex Stephens, Giuseppe Ottone Cirulli, et al.
European Urology Oncology|July 11, 2024
The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American CohortMarco Finati, Matthew Davis, Alex Stephens, et al.
Urologic Oncology|September 6, 2024
Radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer: Analysis of an other-cause mortality matched cohortMarco Finati, Alex Stephens, Giuseppe Chiarelli, et al.
Pageof 5